the PUTTblog

May 20, 2022

Lauren's Legislative Update: May 2022

Many PUTT members use the summer legislative break to invite lawmakers into their stores. This is an excellent opportunity to show your elected officials how many potential voters from their district you interact with daily, so be sure to take advantage if you can.

One highly important thing to remember when discussing proposed legislation with legislators is the matter of “agreed upon bills”. This does not refer to bills "agreed upon" between Independent Pharmacies and PCMA and/or the Health Insurance Plan lobbyists. “Agreed upon bills” means bills agreed upon between business & labor groups like chambers of commerce and unions. Try to make sure you have support from entities of both sides to drive home any reform points. No one assumes we will agree upon a PCMA-supported bill.

Two states that seem to be continuously on the cutting edge of regulation and reform at the state level are Louisiana and Texas. Here are three different trends we believe should be on everyone’s radar:

Lauren's Legislative Update: May 2022

May 19, 2022

A Drugmaker’s Tale: How $34 Billion in Rebates Is Keeping Commercial Insurers and PBMs Flush with Cash While Hanging Everyone Else Out to Dry

Last month, Janssen Pharmaceuticals released its 5th annual U.S. Transparency Report with a notable new addition: a detailed synopsis of how rebates, now hard-wired into insurance benefit design, essentially derail patients from accessing affordable medication.

A Drugmaker’s Tale: How $34 Billion in Rebates Is Keeping Commercial Insurers and PBMs Flush with Cash While Hanging Everyone Else Out to Dry

Mar 4, 2022

The Other March Madness: PUTT's PBM Legislation Scouting Report

As March is storming "in like a lion", recent developments at both the state and federal levels may have PBMs feeling buffaloed. And while February's FTC hearing was deadlocked thanks to the “no” votes of 2 FTC commissioners. PUTT, along with multiple other advocacy organizations responded immediately with statements condemning the move.

The Other March Madness: PUTT's PBM Legislation Scouting Report

Jan 28, 2022

Keeping the Pressure on PBM Reform: Our 2022 Priorities

January marks the start of legislative sessions for most states in the U.S. and is one of the busiest times at PUTT. During the legislative season we monitor hearings and weigh in where invited (or not); seek out and provide evidence where invited (or not); and publish information and documents to help educate legislators and the public understand how PBM abuse harms patients, their employers, and the healthcare system.

Keeping the Pressure on PBM Reform: Our 2022 Priorities

Jan 27, 2022

The Battle for America's Prescription Drug System

Prescription drug cost is one of the few issues everyone can agree needs addressing, yet very few politicians seem able to abandon party-line rhetoric to confront the issue.

The Battle for America's Prescription Drug System

Dec 19, 2021

The Highs, The Lows, & The WTH’s: PUTT’s 2021 Year in Review

If you thought 2021, aka the follow-up to When Satan met 2020, seemed like a mixed bag of forward momentum and frustrating setbacks in the move to reform PBMs, you’re in good company.

The Highs, The Lows, & The WTH’s: PUTT’s 2021 Year in Review

Nov 22, 2021

PBM Reform Is Getting Real

It’s feeling a lot like PBM reform is getting really real as the largest pharmacy benefit managers, especially those that might own or exert enormous influence over large retail pharmacies, come under fire for issues related to real-world concerns for patient safety, drug pricing and limiting access to medications.

PBM Reform Is Getting Real

Oct 25, 2021

Yes, Virginia, PBMs Really Do Suck

Like many community pharmacies, Newman Family Pharmacy is the kind of pharmacy patients choose for its incomparable commitment to service and care.

Yes, Virginia, PBMs Really Do Suck
Follow the PUTTblog on Medium
@puttrx